Pharmaceutical, clinical, and resistance information on doravirine, a novel non-nucleoside reverse transcriptase inhibitor for the treatment of HIV-1 infection

As part of a combined antiretroviral regimen, doravirine is safe and effective at suppressing viral replication in both treatment-naive and treatment-experienced adults living with human immunodeficiency virus (HIV)-1 who have no history of drug resistance against doravirine. In virologically suppre...

Descripción completa

Detalles Bibliográficos
Autores principales: Pham, Hanh Thi, Xiao, Meng A, Principe, Miguel AV, Wong, Alexander, Mesplède, Thibault
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055513/
https://www.ncbi.nlm.nih.gov/pubmed/32180823
http://dx.doi.org/10.7573/dic.2019-11-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055513/
https://www.ncbi.nlm.nih.gov/pubmed/32180823
http://dx.doi.org/10.7573/dic.2019-11-4

Ejemplares similares